SPECTRe: Substructure Processing, Enumeration, and Comparison Tool Resource: An efficient tool to encode all substructures of molecules represented in SMILES
Authors:
Yasemin Yesiltepe,
Ryan S. Renslow,
Thomas O. Metz
Abstract:
Functional groups and moieties are chemical descriptors of biomolecules that can be used to interpret their properties and functions, leading to the understanding of chemical or biological mechanisms. These chemical building blocks, or sub-structures, enable the identification of common molecular subgroups, assessing the structural similarities and critical interactions among a set of biological m…
▽ More
Functional groups and moieties are chemical descriptors of biomolecules that can be used to interpret their properties and functions, leading to the understanding of chemical or biological mechanisms. These chemical building blocks, or sub-structures, enable the identification of common molecular subgroups, assessing the structural similarities and critical interactions among a set of biological molecules with known activities, and designing novel compounds with similar chemical properties. Here, we introduce a Python-based tool, SPECTRe (Substructure Processing, Enumeration, and Comparison Tool Resource), designed to provide all substructures in a given molecular structure, regardless of the molecule size, employing efficient enumeration and generation of substructures represented in a human-readable SMILES format through the use of classical graph traversal (breadth-first and depth-first search) algorithms. We demonstrate the application of SPECTRe for a set of 10,375 molecules in the molecular weight range 27 to 350 Da (<=26 non-hydrogen atoms), spanning a wide array of structure-based chemical functionalities and chemical classes. We found that the substructure count as a measure of molecular complexity depends strongly on the number of unique atom and bond types present, degree of branching, and presence of rings. The substructure counts are found to be similar for a set of molecules belonging to particular chemical classes and classified based on the characteristic features of certain topologies. We demonstrate that SPECTRe shows promise to be useful in many applications of cheminformatics such as virtual screening for drug discovery, property prediction, fingerprint-based molecular similarity searching, and data mining for identifying frequent substructures.
△ Less
Submitted 4 November, 2021;
originally announced November 2021.
Application and Assessment of Deep Learning for the Generation of Potential NMDA Receptor Antagonists
Authors:
Katherine J. Schultz,
Sean M. Colby,
Yasemin Yesiltepe,
Jamie R. Nuñez,
Monee Y. McGrady,
Ryan R. Renslow
Abstract:
Uncompetitive antagonists of the N-methyl D-aspartate receptor (NMDAR) have demonstrated therapeutic benefit in the treatment of neurological diseases such as Parkinson's and Alzheimer's, but some also cause dissociative effects that have led to the synthesis of illicit drugs. The ability to generate NMDAR antagonists in silico is therefore desirable both for new medication development and for pre…
▽ More
Uncompetitive antagonists of the N-methyl D-aspartate receptor (NMDAR) have demonstrated therapeutic benefit in the treatment of neurological diseases such as Parkinson's and Alzheimer's, but some also cause dissociative effects that have led to the synthesis of illicit drugs. The ability to generate NMDAR antagonists in silico is therefore desirable both for new medication development and for preempting and identifying new designer drugs. Recently, generative deep learning models have been applied to de novo drug design as a means to expand the amount of chemical space that can be explored for potential drug-like compounds. In this study, we assess the application of a generative model to the NMDAR to achieve two primary objectives: (i) the creation and release of a comprehensive library of experimentally validated NMDAR phencyclidine (PCP) site antagonists to assist the drug discovery community and (ii) an analysis of both the advantages conferred by applying such generative artificial intelligence models to drug design and the current limitations of the approach. We apply, and provide source code for, a variety of ligand- and structure-based assessment techniques used in standard drug discovery analyses to the deep learning-generated compounds. We present twelve candidate antagonists that are not available in existing chemical databases to provide an example of what this type of workflow can achieve, though synthesis and experimental validation of these compounds is still required.
△ Less
Submitted 31 March, 2020;
originally announced March 2020.
